Literature DB >> 19592458

NADPH oxidases and reactive oxygen species at different stages of chronic hypoxia-induced pulmonary hypertension in newborn piglets.

Kathleen E Dennis1, J L Aschner, D Milatovic, J W Schmidt, M Aschner, M R Kaplowitz, Y Zhang, Candice D Fike.   

Abstract

Recently, we reported that reactive oxygen species (ROS) generated by NADPH oxidase (NOX) contribute to aberrant responses in pulmonary resistance arteries (PRAs) of piglets exposed to 3 days of hypoxia (Am J Physiol Lung Cell Mol Physiol 295: L881-L888, 2008). An objective of the present study was to determine whether NOX-derived ROS also contribute to altered PRA responses at a more advanced stage of pulmonary hypertension, after 10 days of hypoxia. We further wished to advance knowledge about the specific NOX and antioxidant enzymes that are altered at early and later stages of pulmonary hypertension. Piglets were raised in room air (control) or hypoxia for 3 or 10 days. Using a cannulated artery technique, we found that treatments with agents that inhibit NOX (apocynin) or remove ROS [an SOD mimetic (M40403) + polyethylene glycol-catalase] diminished responses to ACh in PRAs from piglets exposed to 10 days of hypoxia. Western blot analysis showed an increase in expression of NOX1 and the membrane fraction of p67phox. Expression of NOX4, SOD2, and catalase were unchanged, whereas expression of SOD1 was reduced, in arteries from piglets raised in hypoxia for 3 or 10 days. Markers of oxidant stress, F(2)-isoprostanes, measured by gas chromatography-mass spectrometry, were increased in PRAs from piglets raised in hypoxia for 3 days, but not 10 days. We conclude that ROS derived from some, but not all, NOX family members, as well as alterations in the antioxidant enzyme SOD1, contribute to aberrant PRA responses at an early and a more progressive stage of chronic hypoxia-induced pulmonary hypertension in newborn piglets.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19592458      PMCID: PMC2770786          DOI: 10.1152/ajplung.90568.2008

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  74 in total

Review 1.  Isoprostanes: an overview and putative roles in pulmonary pathophysiology.

Authors:  L J Janssen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-06       Impact factor: 5.464

2.  The NOX on pulmonary hypertension.

Authors:  Karl A Sanders; John R Hoidal
Journal:  Circ Res       Date:  2007-08-03       Impact factor: 17.367

3.  Electrophysiologically distinct smooth muscle cell subtypes in rat conduit and resistance pulmonary arteries.

Authors:  Sergey V Smirnov; Richard Beck; Paolo Tammaro; Tetsuro Ishii; Philip I Aaronson
Journal:  J Physiol       Date:  2002-02-01       Impact factor: 5.182

4.  Cyclooxygenase contracting factors and altered pulmonary vascular responses in chronically hypoxic newborn pigs.

Authors:  Candice D Fike; Sandra L Pfister; Mark R Kaplowitz; Jane A Madden
Journal:  J Appl Physiol (1985)       Date:  2002-01

5.  Comparison of pulmonary vascular function and structure in early and established hypoxic pulmonary hypertension in rats.

Authors:  T K Jeffery; J C Wanstall
Journal:  Can J Physiol Pharmacol       Date:  2001-03       Impact factor: 2.273

6.  Overestimation of NADH-driven vascular oxidase activity due to lucigenin artifacts.

Authors:  Mariano Janiszewski; Heraldo P Souza; Xiaoping Liu; Marcelo A Pedro; Jay L Zweier; Francisco R M Laurindo
Journal:  Free Radic Biol Med       Date:  2002-03-01       Impact factor: 7.376

Review 7.  Fluorescent and luminescent probes for measurement of oxidative and nitrosative species in cells and tissues: progress, pitfalls, and prospects.

Authors:  Peter Wardman
Journal:  Free Radic Biol Med       Date:  2007-07-10       Impact factor: 7.376

8.  Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature.

Authors:  Manish Mittal; Markus Roth; Peter König; Simone Hofmann; Eva Dony; Parag Goyal; Anne-Christin Selbitz; Ralph Theo Schermuly; Hossein Ardeschir Ghofrani; Grazyna Kwapiszewska; Wolfgang Kummer; Walter Klepetko; Mir Ali Reza Hoda; Ludger Fink; Jörg Hänze; Werner Seeger; Friedrich Grimminger; Harald H H W Schmidt; Norbert Weissmann
Journal:  Circ Res       Date:  2007-06-21       Impact factor: 17.367

Review 9.  Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy.

Authors:  J David Lambeth
Journal:  Free Radic Biol Med       Date:  2007-03-31       Impact factor: 7.376

10.  Regulation of antioxidants and phase 2 enzymes by shear-induced reactive oxygen species in endothelial cells.

Authors:  Charles I Jones; Hong Zhu; Sergio F Martin; Zhaosheng Han; Yunbo Li; B Rita Alevriadou
Journal:  Ann Biomed Eng       Date:  2007-03-06       Impact factor: 3.934

View more
  53 in total

1.  Post-translational modification of Cu/Zn superoxide dismutase under anaerobic conditions.

Authors:  Jeffry M Leitch; Cissy X Li; J Allen Baron; Lauren M Matthews; Xiaohang Cao; P John Hart; Valeria C Culotta
Journal:  Biochemistry       Date:  2012-01-05       Impact factor: 3.162

Review 2.  Reactive oxygen and nitrogen species in pulmonary hypertension.

Authors:  Diana M Tabima; Sheila Frizzell; Mark T Gladwin
Journal:  Free Radic Biol Med       Date:  2012-03-06       Impact factor: 7.376

3.  Pulmonary arterial responses to reactive oxygen species are altered in newborn piglets with chronic hypoxia-induced pulmonary hypertension.

Authors:  Candice D Fike; Judy L Aschner; James C Slaughter; Mark R Kaplowitz; Yongmei Zhang; Sandra L Pfister
Journal:  Pediatr Res       Date:  2011-08       Impact factor: 3.756

4.  Intermittent hypoxia augments pulmonary vascular smooth muscle reactivity to NO: regulation by reactive oxygen species.

Authors:  Charles E Norton; Nikki L Jernigan; Nancy L Kanagy; Benjimen R Walker; Thomas C Resta
Journal:  J Appl Physiol (1985)       Date:  2011-07-14

Review 5.  The role of genetic polymorphisms in antioxidant enzymes and potential antioxidant therapies in neonatal lung disease.

Authors:  Carlo Dani; Chiara Poggi
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

Review 6.  Matricellular protein thrombospondin-1 in pulmonary hypertension: multiple pathways to disease.

Authors:  Natasha M Rogers; Kedar Ghimire; Maria J Calzada; Jeffrey S Isenberg
Journal:  Cardiovasc Res       Date:  2017-07-01       Impact factor: 10.787

7.  Enhanced NO-dependent pulmonary vasodilation limits increased vasoconstrictor sensitivity in neonatal chronic hypoxia.

Authors:  Joshua R Sheak; Laura Weise-Cross; Ray J deKay; Benjimen R Walker; Nikki L Jernigan; Thomas C Resta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-07-21       Impact factor: 4.733

8.  Combined l-citrulline and tetrahydrobiopterin therapy improves NO signaling and ameliorates chronic hypoxia-induced pulmonary hypertension in newborn pigs.

Authors:  Anna Dikalova; Judy L Aschner; Mark R Kaplowitz; Gary Cunningham; Marshall Summar; Candice D Fike
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-02-19       Impact factor: 5.464

9.  Reactive oxygen species-reducing strategies improve pulmonary arterial responses to nitric oxide in piglets with chronic hypoxia-induced pulmonary hypertension.

Authors:  Candice D Fike; Anna Dikalova; James C Slaughter; M R Kaplowitz; Y Zhang; Judy L Aschner
Journal:  Antioxid Redox Signal       Date:  2013-01-29       Impact factor: 8.401

10.  Extracellular dopamine potentiates mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans.

Authors:  Alexandre Benedetto; Catherine Au; Daiana Silva Avila; Dejan Milatovic; Michael Aschner
Journal:  PLoS Genet       Date:  2010-08-26       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.